Division of Infectious Diseases, Tri-Service General Hospital Penghu Branch, Penghu, Taiwan.
Department of Clinical Pathology, National Defense Medical Center, Tri-Service General Hospital, Taiwan.
J Microbiol Immunol Infect. 2022 Feb;55(1):107-113. doi: 10.1016/j.jmii.2020.12.012. Epub 2021 Jan 13.
The emergence of concurrent levofloxacin- and trimethoprim/sulfamethoxazole (TMP/SMX)-resistant Stenotrophomonas maltophilia (LTSRSM) in Taiwan is becoming a serious problem, but clinical data analysis on this has not been reported.
A matched case-control-control study was conducted to investigate risk factors for LTSRSM occurrence in hospitalized patients. For patients with LTSRSM infection/colonization (the case group), two matched control groups were used: control group A with levofloxacin- and TMP/SMX-susceptible S. maltophilia (LTSSSM) and control group B without S. maltophilia. Besides, tigecycline, ceftazidime, cefepime, ciprofloxacin, gentamicin, amikacin, and colistin susceptibilities in collected LTSRSM and levofloxacin- and TMP/SMX-susceptible S. maltophilia (LTSSSM) isolates were compared.
From January 2014 to June 2016, 129 LTSRSM from cultured 1213 S. maltophilia isolates (10.6%) were identified. A total of 107 LTSRSM infected patients paired with 107 LTSSSM-, and 107 non-S. maltophilia-infected ones were included. When compared with control group A, previous fluoroquinolone and TMP/SMX use was found to be independently associated with LTSRSM occurrence. When compared with control group B, mechanical ventilation, cerebrovascular disease, and previous fluoroquinolone use were risk factors for LTSRSM occurrence. Eighty-five LTSRSM and 85 LTSSSM isolates were compared for antibiotic susceptibilities; the resistance rates and minimum inhibitory concentrations of tigecycline and ceftazidime were significantly higher for LTSRSM than for LTSSSM isolates.
The emergence of LTSRSM showing cross resistance to tigecycline and ceftazidime would further limit current therapeutic options. Cautious fluoroquinolone and TMP/SMX use may be helpful to limit such high-level resistant strains of S. maltophilia occurrence.
同时对左氧氟沙星和复方磺胺甲噁唑(TMP/SMX)耐药的嗜麦芽窄食单胞菌(LTSRSM)在台湾的出现已成为一个严重的问题,但尚未有关于此的临床数据分析报告。
采用病例对照对照研究,调查住院患者发生 LTSRSM 的危险因素。对 LTSRSM 感染/定植患者(病例组),采用两种配对对照:对左氧氟沙星和 TMP/SMX 敏感的嗜麦芽窄食单胞菌(LTSSSM)对照组 A 和无嗜麦芽窄食单胞菌对照组 B。此外,比较收集的 LTSRSM 和左氧氟沙星及 TMP/SMX 敏感的嗜麦芽窄食单胞菌(LTSSSM)分离株对替加环素、头孢他啶、头孢吡肟、环丙沙星、庆大霉素、阿米卡星和粘菌素的敏感性。
2014 年 1 月至 2016 年 6 月,从 1213 株嗜麦芽窄食单胞菌分离株中鉴定出 129 株 LTSRSM(10.6%)。共纳入 107 例感染 LTSRSM 患者、107 例感染 LTSSSM 患者和 107 例未感染嗜麦芽窄食单胞菌患者。与对照组 A 相比,既往氟喹诺酮类和 TMP/SMX 药物使用与 LTSRSM 发生独立相关。与对照组 B 相比,机械通气、脑血管疾病和既往氟喹诺酮类药物使用是 LTSRSM 发生的危险因素。比较 85 株 LTSRSM 和 85 株 LTSSSM 分离株的抗生素药敏性;LTSRSM 分离株对替加环素和头孢他啶的耐药率和最小抑菌浓度明显高于 LTSSSM 分离株。
LTSRSM 对替加环素和头孢他啶的交叉耐药性的出现将进一步限制目前的治疗选择。谨慎使用氟喹诺酮类和 TMP/SMX 可能有助于限制嗜麦芽窄食单胞菌高水平耐药菌株的发生。